Andrew McKenzie’s group, in the LMB’s PNAC Division, have applied a new screening system and synthetic Boolean logic gate circuits to offer unprecedented insights into the molecular regulation of type-2 innate lymphoid cells, a key contributor to allergic responses.
Transcription factor Mef2d is crucial to the function of type-2 innate lymphoid cells during allergic responses
Polish Waves on Cambridge 105 Radio featuring Dariusz Czernecki
LMB Investigator Scientist, Dariusz Czernecki, recently featured on Cambridge 105 Radio’s ‘Polish Waves’ programme. Listen to hear Dariusz chat about his curiosity-driven career path which has taken him from Poland to France to Cambridge, explain what molecular biology is and the kind of techniques used at the LMB, and what his research involves and aims […]
Tony Kouzarides knighted in King’s Birthday Honours List
LMB 1982-1983, 1984-1986, Postdoctoral Scientist, PNAC Tony Kouzarides, Director of the Milner Therapeutics Institute, Professor of Cancer Biology at the University of Cambridge, and Senior Group Leader at the Gurdon Institute, has received a knighthood in the 2024 King’s Birthday Honours List for ‘services to healthcare innovation and delivery’. He completed postdoctoral research in the […]
Keren Turton appointed as Tissue Culture Facility Manager
Keren Turton recently joined the LMB as Tissue Culture Facility Manager, where she assists research through cultivation of insect and mammalian cells for protein expression.
Karl Golser Parkinson Prize awarded to Michel Goedert
Michel Goedert, Group Leader in the LMB’s Neurobiology Division, has been awarded the 2024 Karl Golser Parkinson Prize for his work on the molecular mechanisms of Parkinson’s disease and atypical parkinsonian disorders.
Paramjit Sehmi joins the LMB as new Archivist
The LMB welcomes Paramjit Sehmi as the new Archivist and Engagement Officer.